A Single-arm, Open-label Study of Avastin Plus Xeloda on Objective Treatment Response in Patients With Advanced or Metastatic Liver Cancer Who Have Had no Previous Cytotoxic Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 24 Jan 2014
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Roche
- 20 Dec 2013 New source identified and integrated (ClinicalTrials.gov; NCT02013830)
- 23 Feb 2010 Status changed from active, no longer recruiting to completed as reported by Roche record.
- 08 Jun 2006 New trial record.